The global race toward needle-free drug delivery is accelerating through strategic partnerships between device innovators and pharmaceutical manufacturers.

Innovation is reshaping the needle-free injector landscape, as med-tech companies race to develop devices that are smarter, safer, and easier to use.

Needle-Free Injectors Enter Mainstream as Demand for Pain-Free Delivery Surges

November 2025 | Vienna, Austria
Quinovare will participate in BIO-Europe 2025, taking place from November 3–5, 2025, in Vienna, Austria. BIO-Europe is one of the leading global partnering conferences for the biopharmaceutical industry, bringing together pharmaceutical, biotech, and investment stakeholders.

Quinovare will participate in CPHI Frankfurt 2025, taking place from October 28–30, 2025. The exhibition brings together global pharmaceutical and biotech stakeholders to discuss development, manufacturing, and delivery technologies across the industry.

QS Medical (Quinovare) will participate in BIOHK 2025, taking place from September 10–13, 2025, in Hong Kong.